Bedrijfsoverzicht
Align Technology, Inc. is a leading provider of digital orthodontic solutions, primarily known for its Invisalign clear aligners, which address malocclusion in adult and teen patients, alongside its Vivera retainers and iTero intraoral scanning services. The company operates within the Healthcare sector, specifically in the Medical Instruments & Supplies industry, positioning it at the intersection of advanced manufacturing and specialized medical device distribution. Align Technology, Inc. holds a market capitalization of $12.40B and generated $4.03B in annual revenue while employing 20,290 individuals globally. These valuation and revenue figures indicate a substantial market footprint, suggesting the company has achieved significant scale and dominance in the clear aligner segment across the United States, Switzerland, and international markets.
Financiële gezondheid
The company reported $4.03B in revenue and $410.35M in net income over the trailing twelve months, with EBITDA reaching $851.35M. The substantial gap between total revenue of $4.03B and net income of $410.35M reveals a cost structure where operating expenses and taxes consume approximately 89.8% of gross sales before reaching the bottom line. However, the business generates strong free cash flow of $483.69M, which provides significant financial flexibility for capital allocation, debt repayment, or potential strategic acquisitions without relying heavily on external financing. The company maintains a gross margin of 69.8%, reflecting high pricing power and efficient production costs typical of proprietary digital manufacturing. Operating margins stand at 22.4%, indicating that after covering all operating expenses, the company retains a healthy portion of revenue to cover taxes and interest. The profit margin is 10.2%, which represents the final percentage of revenue converted into net earnings available to shareholders. On the balance sheet, cash assets of $1.09B significantly exceed total debt obligations of $114.45M, supported by a debt-to-equity ratio of 2.83, suggesting a leveraged position where debt is used to finance operations but is well-covered by equity. Despite the leverage, the current ratio of 1.36 indicates that the company possesses sufficient current assets to cover its short-term liabilities, ensuring robust short-term liquidity. Return on equity is 10.4% and return on assets is 6.9%, metrics that reveal management's effectiveness in generating profits from the shareholder's investment and utilizing the company's asset base respectively.
Waarderingsbeoordeling
Align Technology, Inc. trades with a trailing P/E ratio of 30.70 and a forward P/E ratio of 14.11. The significant disparity between the trailing P/E of 30.70 and the forward P/E of 14.11 implies that the market expects earnings to increase substantially in the coming year, potentially driven by operational efficiencies or expansion in international markets. The price-to-book ratio stands at 3.05, indicating that the market values the company at more than three times its book value, which suggests investors are pricing in high growth potential and intangible assets rather than just tangible equity. Alternative valuation metrics include a price-to-sales ratio of 3.07 and an EV/EBITDA of 13.35, which provide context that the company is valued at a premium relative to its sales but remains reasonable when adjusted for earnings and enterprise value. The stock has traded between a 52-week high of $208.31 and a 52-week low of $122.00, meaning the current price sits at a level that reflects recent volatility but remains well below the peak observed in the last year. The beta value is 1.81, which indicates that the stock's price volatility is significantly higher than the broader market, moving roughly 81% more aggressively than the overall market index during periods of fluctuation.
Growth & Income
Revenue growth stands at 5.3% year-over-year, while earnings growth is reported at 35.6% year-over-year. This divergence indicates that earnings are growing at a much faster pace than revenue, implying that the company is successfully improving its operational efficiency or benefiting from leverage effects that amplify profit margins even with modest top-line expansion. Align Technology, Inc. does not pay a dividend, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning the company reinvests all of its earnings back into the business to fund research, development, and market expansion rather than distributing cash to shareholders. Consequently, the company's growth profile is entirely reliant on organic expansion, acquisitions, or product innovation rather than income generation through dividends. This reinvestment strategy is typical for high-growth technology and medical device firms that prioritize compounding growth over immediate shareholder cash returns.